These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

144 related items for PubMed ID: 30737270

  • 1. Treatment with 2,4-Dihydroxybenzoic Acid Prevents FSGS Progression and Renal Fibrosis in Podocyte-Specific Coq6 Knockout Mice.
    Widmeier E, Airik M, Hugo H, Schapiro D, Wedel J, Ghosh CC, Nakayama M, Schneider R, Awad AM, Nag A, Cho J, Schueler M, Clarke CF, Airik R, Hildebrandt F.
    J Am Soc Nephrol; 2019 Mar; 30(3):393-405. PubMed ID: 30737270
    [Abstract] [Full Text] [Related]

  • 2. ADCK4 Deficiency Destabilizes the Coenzyme Q Complex, Which Is Rescued by 2,4-Dihydroxybenzoic Acid Treatment.
    Widmeier E, Yu S, Nag A, Chung YW, Nakayama M, Fernández-Del-Río L, Hugo H, Schapiro D, Buerger F, Choi WI, Helmstädter M, Kim JW, Ryu JH, Lee MG, Clarke CF, Hildebrandt F, Gee HY.
    J Am Soc Nephrol; 2020 Jun; 31(6):1191-1211. PubMed ID: 32381600
    [Abstract] [Full Text] [Related]

  • 3. New Mutation of Coenzyme Q10 Monooxygenase 6 Causing Podocyte Injury in a Focal Segmental Glomerulosclerosis Patient.
    Song CC, Hong Q, Geng XD, Wang X, Wang SQ, Cui SY, Guo MD, Li O, Cai GY, Chen XM, Wu D.
    Chin Med J (Engl); 2018 Nov 20; 131(22):2666-2675. PubMed ID: 30425193
    [Abstract] [Full Text] [Related]

  • 4.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 5. [Coenzyme Q(10) treatment for one child with COQ6 gene mutation induced nephrotic syndrome and literature review].
    Cao Q, Li GM, Xu H, Shen Q, Sun L, Fang XY, Liu HM, Guo W, Zhai YH, Wu BB.
    Zhonghua Er Ke Za Zhi; 2017 Feb 02; 55(2):135-138. PubMed ID: 28173653
    [Abstract] [Full Text] [Related]

  • 6. ADCK4 mutations promote steroid-resistant nephrotic syndrome through CoQ10 biosynthesis disruption.
    Ashraf S, Gee HY, Woerner S, Xie LX, Vega-Warner V, Lovric S, Fang H, Song X, Cattran DC, Avila-Casado C, Paterson AD, Nitschké P, Bole-Feysot C, Cochat P, Esteve-Rudd J, Haberberger B, Allen SJ, Zhou W, Airik R, Otto EA, Barua M, Al-Hamed MH, Kari JA, Evans J, Bierzynska A, Saleem MA, Böckenhauer D, Kleta R, El Desoky S, Hacihamdioglu DO, Gok F, Washburn J, Wiggins RC, Choi M, Lifton RP, Levy S, Han Z, Salviati L, Prokisch H, Williams DS, Pollak M, Clarke CF, Pei Y, Antignac C, Hildebrandt F.
    J Clin Invest; 2013 Dec 02; 123(12):5179-89. PubMed ID: 24270420
    [Abstract] [Full Text] [Related]

  • 7. Effect of vanillic acid on COQ6 mutants identified in patients with coenzyme Q10 deficiency.
    Doimo M, Trevisson E, Airik R, Bergdoll M, Santos-Ocaña C, Hildebrandt F, Navas P, Pierrel F, Salviati L.
    Biochim Biophys Acta; 2014 Jan 02; 1842(1):1-6. PubMed ID: 24140869
    [Abstract] [Full Text] [Related]

  • 8. COQ6 Mutations in Children With Steroid-Resistant Focal Segmental Glomerulosclerosis and Sensorineural Hearing Loss.
    Park E, Ahn YH, Kang HG, Yoo KH, Won NH, Lee KB, Moon KC, Seong MW, Gwon TR, Park SS, Cheong HI.
    Am J Kidney Dis; 2017 Jul 02; 70(1):139-144. PubMed ID: 28117207
    [Abstract] [Full Text] [Related]

  • 9. Inhibition of Importin- α -Mediated Nuclear Localization of Dendrin Attenuates Podocyte Loss and Glomerulosclerosis.
    Empitu MA, Kikyo M, Shirata N, Yamada H, Makino SI, Kadariswantiningsih IN, Aizawa M, Patrakka J, Nishimori K, Asanuma K.
    J Am Soc Nephrol; 2023 Jul 01; 34(7):1222-1239. PubMed ID: 37134307
    [Abstract] [Full Text] [Related]

  • 10. Effects of a novel ANLN E841K mutation associated with SRNS on podocytes and its mechanism.
    Lin L, Ye Y, Fu H, Gu W, Zhao M, Sun J, Cao Z, Huang G, Xie Y, Liu F, Li L, Li Q, Mao J, Hu L.
    Cell Commun Signal; 2023 Nov 13; 21(1):324. PubMed ID: 37957688
    [Abstract] [Full Text] [Related]

  • 11. Intrinsic tumor necrosis factor-α pathway is activated in a subset of patients with focal segmental glomerulosclerosis.
    Chung CF, Kitzler T, Kachurina N, Pessina K, Babayeva S, Bitzan M, Kaskel F, Colmegna I, Alachkar N, Goodyer P, Cybulsky AV, Torban E.
    PLoS One; 2019 Nov 13; 14(5):e0216426. PubMed ID: 31095586
    [Abstract] [Full Text] [Related]

  • 12. Primary coenzyme Q10 Deficiency-6 (COQ10D6): Two siblings with variable expressivity of the renal phenotype.
    Yuruk Yildirim Z, Toksoy G, Uyguner O, Nayir A, Yavuz S, Altunoglu U, Turkkan ON, Sevinc B, Gokcay G, Kurkcu Gunes D, Kiyak A, Yilmaz A.
    Eur J Med Genet; 2020 Jan 13; 63(1):103621. PubMed ID: 30682496
    [Abstract] [Full Text] [Related]

  • 13. COQ6 mutation in patients with nephrotic syndrome, sensorineural deafness, and optic atrophy.
    Justine Perrin R, Rousset-Rouvière C, Garaix F, Cano A, Conrath J, Boyer O, Tsimaratos M.
    JIMD Rep; 2020 Jul 13; 54(1):37-44. PubMed ID: 32685349
    [Abstract] [Full Text] [Related]

  • 14. Transcription factor MafB in podocytes protects against the development of focal segmental glomerulosclerosis.
    Usui T, Morito N, Shawki HH, Sato Y, Tsukaguchi H, Hamada M, Jeon H, Yadav MK, Kuno A, Tsunakawa Y, Okada R, Ojima T, Kanai M, Asano K, Imamura Y, Koshida R, Yoh K, Usui J, Yokoi H, Kasahara M, Yoshimura A, Muratani M, Kudo T, Oishi H, Yamagata K, Takahashi S.
    Kidney Int; 2020 Aug 13; 98(2):391-403. PubMed ID: 32622525
    [Abstract] [Full Text] [Related]

  • 15. Podocyte-Specific Sialylation-Deficient Mice Serve as a Model for Human FSGS.
    Niculovic KM, Blume L, Wedekind H, Kats E, Albers I, Groos S, Abeln M, Schmitz J, Beuke E, Bräsen JH, Melk A, Schiffer M, Weinhold B, Münster-Kühnel AK.
    J Am Soc Nephrol; 2019 Jun 13; 30(6):1021-1035. PubMed ID: 31040189
    [Abstract] [Full Text] [Related]

  • 16. Podocyte-specific Nup160 knockout mice develop nephrotic syndrome and glomerulosclerosis.
    Li Y, Xu C, Zhao F, Liu Q, Qiu X, Li M, Yang Y, Yu S, Tong H, Zhang L, Chen B, Qu L, Yu Z.
    Hum Mol Genet; 2024 Apr 08; 33(8):667-676. PubMed ID: 38224683
    [Abstract] [Full Text] [Related]

  • 17. Podocyte-Specific Deletion of Yes-Associated Protein Causes FSGS and Progressive Renal Failure.
    Schwartzman M, Reginensi A, Wong JS, Basgen JM, Meliambro K, Nicholas SB, D'Agati V, McNeill H, Campbell KN.
    J Am Soc Nephrol; 2016 Jan 08; 27(1):216-26. PubMed ID: 26015453
    [Abstract] [Full Text] [Related]

  • 18. Oral Coenzyme Q10 supplementation leads to better preservation of kidney function in steroid-resistant nephrotic syndrome due to primary Coenzyme Q10 deficiency.
    Drovandi S, Lipska-Ziętkiewicz BS, Ozaltin F, Emma F, Gulhan B, Boyer O, Trautmann A, Xu H, Shen Q, Rao J, Riedhammer KM, Heemann U, Hoefele J, Stenton SL, Tsygin AN, Ng KH, Fomina S, Benetti E, Aurelle M, Prikhodina L, Schreuder MF, Tabatabaeifar M, Jankowski M, Baiko S, Mao J, Feng C, Liu C, Sun S, Deng F, Wang X, Clavé S, Stańczyk M, Bałasz-Chmielewska I, Fila M, Durkan AM, Levart TK, Dursun I, Esfandiar N, Haas D, Bjerre A, Anarat A, Benz MR, Talebi S, Hooman N, Ariceta G, PodoNet Consortium, mitoNET Consortium, CCGKDD Consortium, Schaefer F.
    Kidney Int; 2022 Sep 08; 102(3):604-612. PubMed ID: 35643375
    [Abstract] [Full Text] [Related]

  • 19. Use of genomic and functional analysis to characterize patients with steroid-resistant nephrotic syndrome.
    Kitzler TM, Kachurina N, Bitzan MM, Torban E, Goodyer PR.
    Pediatr Nephrol; 2018 Oct 08; 33(10):1741-1750. PubMed ID: 29982877
    [Abstract] [Full Text] [Related]

  • 20. Endothelial mitochondrial oxidative stress determines podocyte depletion in segmental glomerulosclerosis.
    Daehn I, Casalena G, Zhang T, Shi S, Fenninger F, Barasch N, Yu L, D'Agati V, Schlondorff D, Kriz W, Haraldsson B, Bottinger EP.
    J Clin Invest; 2014 Apr 08; 124(4):1608-21. PubMed ID: 24590287
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 8.